Physician profile
Cj Pollet
NPI 1700846581
$7,647.53
in general payments reported to CMS, 2019-2025
20 companies · $623 in 2025
The $623 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,971 · 2020: $465 · 2021: $1,049 · 2022: $1,296 · 2023: $1,304 · 2024: $940 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,711 · Entertainment: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,711.32 |
| Entertainment | $156.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,806.57 | 2019-2021 | |
| Alcon Vision LLC | $960.06 | 2019-2025 | Total30, Precision 1, Eysuvis |
| Johnson & Johnson Vision Care, INC. | $944.76 | 2020-2025 | Acuvue |
| Oyster Point Pharma, INC. | $633.53 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Coopervision INC. | $600.73 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $498.80 | 2022-2025 | Infuse, Miebo |
| Sun Pharmaceutical Industries INC. | $363.11 | 2019-2025 | Cequa |
| Kala Pharmaceuticals, INC. | $253.09 | 2021-2022 | |
| Rxsight INC | $240.36 | 2022 | |
| Dompe US, INC. | $226.33 | 2023-2025 | Oxervate |
| Abbvie INC. | $192.96 | 2022-2024 | |
| Allergan, INC. | $185.26 | 2020-2022 | |
| Optos, INC. | $156.00 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $152.57 | 2024-2025 | Xdemvy |
| Maculogix, INC. | $123.86 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $118.52 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $117.65 | 2024 | Tecnis Simplicity, Veritas Vision System, Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $37.34 | 2022 | |
| Biotissue Holdings INC. | $19.00 | 2021 | |
| Beaver-Visitec International, INC. | $17.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cj Pollet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.